> Handbook of Disease Burdens and Quality of Life Measures

Handbook of Disease Burdens and Quality of Life Measures

Go

Welcome to the homepage of Handbook of Disease Burdens and Quality of Life Measures, a comprehensive reference work from Springer.

It is the first comprehensive work to address new methods of assessment and analyze new quality of life findings on an international scale. It describes and assesses quantitative measures of quality of life, life expectancy, and the financial costs of illness and treatment.

Information and more details about the extent of this project can be found under Aims & Scope.

Victor R. Preedy, Ronald R. Watson

(Editors in Chief)

  1. The International Classification of Functioning, Disability and Health: A Tool to Classify and Measure Functioning
  2. The Keele Assessment of Participation
  3. The Global Person Generated Index
  4. The Total Illness Burden Index
  5. The EQ-5D Health-Related Quality of Life Questionnaire
  6. The University of Washington Quality of Life Scale
  7. Comparison of Three Quality of Life Questionnaires in Urinary Incontinence
  8. Overview of Instruments Used to Assess Quality of Life in Dentistry
  9. SQOR-V: A Patient Reported Outcome Specifically Dedicated to Chronic Venous Disorders
  10. The Uniscale Assessment of Quality of Life: Applications to Oncology
  11. The Bone Metastases Quality of Life Questionnaire
  12. The Impact of Weight on Quality of Life Questionnaire
  13. The Quality in Later Life Questionnaire
  14. The MacDQOL Individualized Measure of the Impact of Macular Disease on Quality of Life
  15. Development and Assessment of Chinese General Quality of Life Instrument
  16. The Japanese Version of the EORTC Quality of Life Questionnaire
  17. Calculating QALYs and DALYs: Methods and Applications to Fatal and Non-Fatal Conditions
  18. Accuracy of Death Certifications and the Implications for Studying Disease Burdens
  19. Completeness and Accuracy of Death Dates and the Implications for Studying Disease Burdens: Focus on Alternative Data Sources
  20. Utility Scores for Comorbid Conditions: Methodological Issues and Advances
  21. Subjective Quality of Life Measures - General Principles and Concepts
  22. Standard Expected Years of Life Lost as a Measure of Disease Burden: An Investigation of Its Presentation, Meaning and Interpretation
  23. Health-Adjusted Life Expectancy: Concepts and Estimates
  24. Individual Disability-Adjusted Life Year: A Summary Health Outcome Indicator Used for Prospective Studies
  25. Integration of Quality of Life and Survival for Comparative Risk/Outcome Assessment in Healthcare Industry
  26. Disability-Adjusted Life Years in Occupational Injuries and Accidents
  27. The Income-Associated Burden of Disease in the United States
  28. Financial Burdens and Disability-Adjusted Life Years in Los Angeles County
  29. Burden of Disease Between Two Time Frames: Mexico Perspectives
  30. East/West Differences in Health in Europe: Rates, Expectancies and DALYs
  31. The Burden of Neglected Diseases in Developing Countries
  32. The Burden of Communicable and Non-Communicable Diseases in Developing Countries
  33. Economic Evaluation of Health Interventions: Tanzania Perspectives
  34. The Burden of Disease and Injury in Serbia
  35. Disease Burdens and Disability-Adjusted Life Years in Aboriginal and Non-Aboriginal Populations
  36. The Relationship Between the National Health Insurance Expenditures and the Burden of Disease Measures in the Iran
  37. The Burden of Maternal Mortality and Morbidity in the United States and Worldwide
  38. The Financial Implications of Pancreas Transplant Complications
  39. The Use of Pharmacoepidemiological Databases to Assess Disease Burdens: Application to Diabetes
  40. Years of Life Lost Due to Air Pollution in Switzerland: A Dynamic Exposure-Response Model
  41. Quantification of Deaths and DALYs Due to Chronic Exposure to Arsenic in Groundwaters Utilized for Drinking, Cooking and Irrigation of Food-Crops
  42. Disability-Adjusted Life Years in Children and Adolescents in Europe
  43. Disease Burden of Diarrheal and Respiratory Disorders in Children: Hong Kong Perspectives
  44. Burden of Disease in Elderly Mexican Population
  45. Years of Life Lost from Cancer and Applications to Research Funding
  46. Worldwide Burden of Gynecological Cancer
  47. Years of Life Lost from Lung, Stomach, Liver and Cervical Cancers: An Evaluation of the Top Cancer Killers
  48. Burden of Cancer in Serbia
  49. The Disease Burden of Mastectomy: Turkish Perspective and Impact on the Patient and Family
  50. The Burden of Chemotherapy Induced Nausea and Vomiting on Patients' Daily Lives: Italian Perspectives
  51. Atherosclerotic Burden and Mortality
  52. Burden of Cardiovascular Diseases Among Aboriginal and Torres Strait Islander Peoples: Mortality, Hospitalization and Risk Factors
  53. Burden of Ischemic Heart Diseases in Serbia
  54. Burden of Cerebrovascular Diseases (Stroke) in Serbia
  55. DALYs and Public Health Programs for Stroke: Australian Perspectives
  56. Burden of Stroke: Indian Perspective
  57. Disability-Adjusted Life Years, Years of Life Lived with Disability, and Years of Life Lost in Stroke: Italian Perspectives
  58. Burden of Ischemic Stroke and Benefits of Stroke Unit Care and Thrombolytic Therapy
  59. Economic Burden of Complications During Percutaneous Coronary Intervention
  60. Features of Mediterranean Diet and Burden of Cardiovascular Disease
  61. Obesity's Final Toll: Influence on Mortality Rate, Attributable Deaths, Years of Life Lost and Population Life Expectancy
  62. Financial Impact of Obesity
  63. Burden of Disease Attributable to Obesity and Overweight: Korean Focus
  64. Economic Burden of the Components of the Metabolic Syndrome
  65. Zinc Deficiency and DALYs in India: Impact Assessment and Economic Analyses
  66. The Impact of Infectious Diseases on the Development of Africa
  67. Measuring the Global Burden of Tuberculosis
  68. Burden of Tuberculosis: Serbian Perspectives
  69. DALYs and Diarrhea
  70. The Burden of Rotavirus Acute Gastroenteritis in Europe
  71. The Economic Burden of Rotavirus Diarrhea: Taiwan Perspectives
  72. Disease Burden of Dengue Fever and Dengue Hemorrhagic Fever
  73. Cost-Effectiveness of a Dengue Vaccine in Southeast Asia and Panama: Preliminary Estimates
  74. Burden of Sexually Transmitted Chlamydia trachomatis Infections
  75. Disease Burden from Group A Neisseria meningitidis Meningitis in Hyperendemic Countries of the African Meningitis Belt
  76. DALYs in Chronic Hepatitis C : A Paneuropean Perspective
  77. Economics and Vaccines
  78. Economic Costs and Disability-Adjusted Life Years in Polio Eradication: A Long-Run Global Perspective
  79. Financial Burdens and Disability-Adjusted Life Years in Echinococcosis
  80. Measuring Japanese Encephalitis (JE) Disease Burden in Asia
  81. Pandemic Influenza: Potential Contribution to Disease Burden
  82. Prophylaxis of Healthcare Workers in an Influenza Pandemic
  83. The Burden of Human African Trypanosomiasis
  84. The Economic Burden of Malaria in Nigeria and Willingness to Pay
  85. Measurement of Adverse Health Burden Related to Sexual Behavior
  86. Global Burden of Mental Health
  87. Disease Burden and Disability-Adjusted Life Years Due to Schizophrenia and Psychotic Disorders
  88. The Societal Costs of Anxiety and Mood Disorders: An Epidemiological Perspective
  89. Estimating the Disease Burden of Combat-Related Posttraumatic Stress Disorder in United States Veterans and Military Service Members
  90. Estimating the Disease Burden of Seasonal Affective Disorder
  91. The Disease Burden of Suicide: Conceptual Challenges and Measurement Standards
  92. The Disease Burden Due to Epilepsy in Rural China
  93. Alcohol Consumption and Burden of Disease: Germany and Switzerland
  94. Alcoholic Beverage Preference, Morbidity and Mortality
  95. Burden of Disease Due to Alcohol and Alcohol Related Research
  96. Years Life Lost Due to Smoking: A Korean Focus
  97. The Health and Economic Consequences of Smoking and Smoking Cessation Interventions: The Dutch Perspective
  98. Life Years Saved, Quality-Adjusted Life Years Saved and Cost-Effectiveness of a School-Based Tobacco Prevention Program
  99. Burden of Disease and Years Lived with Disability Associated with Musculoskeletal Pain
  100. Financial Burdens and Disability-Adjusted Life Years in Loss of Vision Due to Trachoma
  101. The Economic Burden of Rheumatoid Arthritis: Asia/Thailand Perspective
  102. Quality of Life-Related Concepts: Theoretical and Practical Issues
  103. Alternative Therapies and Quality of Life
  104. Leisure-Time Physical Activity and Quality of Life
  105. Spa Therapy and Quality of Life
  106. Health-Related Quality of Life and Prioritization Strategies in Waiting Lists: Spanish Aspects
  107. Hirsutism and Quality of Life
  108. Oral Health-Related Quality of Life
  109. Quality of Life Issues in Chronic Fatigue Syndrome
  110. Hemoglobin Fluctuations and Correlation with Quality of Life and Fatigue
  111. Anemia and Quality of Life: Association with Diagnosis and Treatment of Anemias
  112. Quality of Life in Hemophilia
  113. Quality of Life in Amenorrhea and Oligomenorrhea
  114. Quality of Life Among Japanese Oral Contraceptive Users
  115. Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Issues of Quality of Life, Stress and Exercise
  116. Quality of Life and Infertility
  117. Speech Determines Quality of Life Following Total Laryngectomy: The Emperors New Voice?
  118. Health-Related Quality of Life of Living Kidney Donors
  119. Quality of Life and Tryptophan Degradation
  120. L-Carnitine Supplementation on Quality of Life and Other Health Measures
  121. Quality of Life Among Diabetic Subjects: Indian Perspectives
  122. Healthy Lifestyle Habits and Health-Related Quality of Life in Diabetes
  123. Quality of Life in Patients with Diabetic Foot Ulcers
  124. Obstructive Sleep Apnea Hypopnea Syndrome and Quality of Life
  125. Quality of Life and Pruritus
  126. Quality of Life and Costs in Atopic Dermatitis
  127. Quality of Life in Crohn's Disease
  128. Impact of Self-Perceived Bothersomeness, Quality of Life and Overactive Bladder
  129. Quality of Life in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
  130. Quality of Life in Kidney Transplantation
  131. Quality of Life in Liver Cirrhosis
  132. Quality of Life and Functional Outcome in Pediatric Patients Requiring Surgery: Italian Perspectives
  133. Breast Reduction Surgery and Quality of Life and Clinical Outcomes
  134. Quality of Life and Postoperative Anesthesia in Gastrointestinal Surgery
  135. Health-Related Quality of Life After Surgery for Crohn's Disease
  136. Postoperative Quality of Life Assessment in the Over 80's After Cardiac Surgery
  137. Quality of Life and Financial Measures in Surgical and Non-Surgical Treatments in Emphysema
  138. Quality of Life After Revascularization and Major Amputation for Lower Extremity Arterial Disease
  139. Quality of Life After Laser Surgery for Eye Disorders
  140. Intrauterine Growth Restriction and Later Quality of Life
  141. Assessment of Quality of Life During Pregnancy and in the Postnatal Period
  142. Generic Quality of Life Measures for Children and Adolescents
  143. Quality of Life in Children with Cerebral Palsy
  144. Quality of Life Measures in Children with Cancer
  145. Quality of Life in Healthy and Chronically Ill Icelandic Children: Agreement Between Child's Self-Report and Parents' Proxy-Report
  146. Health-Related Quality of Life in Obese Children and Adolescents
  147. Implementing Interventions to Enhance Quality of Life in Overweight Children and Adolescents
  148. Adolescent Quality of Life in Australia
  149. Health-Related Quality of Life Among University Students
  150. The Quality of Life and the Impact of Interventions on the Health Outcomes of Looked After and Accommodated Young People
  151. Quality of Life Measures During the Menopause
  152. Low Testosterone Level in Men and Quality of Life
  153. Measuring Quality of Life in Macular Degeneration
  154. Quality of Life Measures in the Elderly and Later Life
  155. Cochlear Implant Outcomes and Quality of Life in the Elderly
  156. Back Pain and Quality of Life in Elderly Women
  157. Measuring Quality of Life at the End of Life
  158. Quality of Life Measures in the Elderly and the Role of Social Support in Elderly Chinese
  159. Quality of Life in Elderly Dyspnea Patients
  160. Quality of Life and Age Urinary Incontinence Severity: Turkish Perspectives
  161. Quality of Life Measures in Elderly Patients with Chronic Obstructive Pulmonary Disease: Japanese Perspectives
  162. Chemotherapy for Brain Metastasis and Quality of Life
  163. Quality of Life Measures in Patients with Esophageal Cancer
  164. Quality of Life Measures in Head and Neck Cancer
  165. Quality of Life in Breast Cancer Patients: An Overview of the Literature
  166. Quality of Life with Localized Prostate Cancer: Japanese Perspectives
  167. Quality of Life in Men Undergoing Radical Prostatectomy for Prostate Cancer
  168. Myeloproliferative Disorders and the Chronic Leukemias: Symptom Burden and Impact in Quality of Life
  169. Quality of Life in Advanced Renal Cell Carcinoma: Effect of Treatment with Cytokine Therapy and Targeted Agents
  170. Quality of Life for Patients Receiving Cancer Chemotherapy: The Japanese Perspective
  171. Quality of Life Measures in Caregivers of Patients with Cancer
  172. Cancer: Influence of Nutrition on Quality of Life
  173. Quality of Life, Drugs and Diet in Hypertensive Patients
  174. Measurement Issues in the Assessment of Quality of Life in Patients with Coronary Heart Disease
  175. Influence of Age, Sex and Episode Recurrence on Quality of Life in Atrial Fibrillation
  176. Quality of Life Measures in Acute Coronary Syndromes: The Evaluation of Predictors in this Field of Research
  177. Home Mechanical Ventilation and Quality of Life Measures
  178. Quality of Life in Children with Asthma
  179. Efficacy of Environmental Interventions on Asthma-Related Quality of Life
  180. Chronic Obstructive Pulmonary Disease, Lung Function and Quality of Life in Adult Chinese
  181. Health-Related Quality of Life in Eating Disorders
  182. Weight-Related Stigmatization: Effects on the Quality of Life of Obese Adolescents
  183. Malnutrition in Chronic Kidney Disease and Relationship to Quality of Life
  184. Nutrition and Quality of Life in Hemodialysis - the Impact of Nutritional Status and Quality of Life on Morbidity and Mortality in Hemodialysis Patients
  185. Nutritional Wasting in Cancer and Quality of Life: The Value of Early Individualized Nutritional Counseling
  186. Quality of Life Measures in HIV Low Income Women: How to Use Quality of Life to Design, Implement and Evaluate Programs
  187. Quality of Life and Financial Measures in HIV/AIDS in Southern Africa
  188. Quality of Life in Immune Thrombocytopenic Purpura: China Perspectives
  189. Health-Related Quality of Life in Adults with Systemic Lupus Erythematosus
  190. Translation, Cultural Adaptation and Validation of Health-Related Quality of Life Assessment Tools: A Brazilian Perspective on Patients with Systemic Lupus Erythematosus
  191. Cognitive Function, Mood and Health-Related Quality of Life in Hepatitis C Virus-Infected Individuals
  192. Quality of Life in Urticaria
  193. Quality of Life in Group-Based Intervention Program in Inflammatory Bowel Disease
  194. Housing and Quality of Life: An Ecological Perspective
  195. Quality of Life of Urban Slum Residents
  196. Quality of Life and Chronic Illness among Refugee Populations
  197. Health-Related Quality of Life in Prisoners
  198. Quality of Life in War Veterans
  199. Post-Traumatic Stress Disorder and Quality of Life in Women
  200. Relation Between Sexuality and Health-Related Quality of Life
  201. The Correlations Between the Presence of Comorbidities, Psychological Distress and Health-Related Quality of Life
  202. Quality of Life and Stigma
  203. Depressive Symptoms and Health-Related Quality of Life
  204. Quality of Life and Depression in Patient-Giver Scenarios: Reference to Amyotrophic Lateral Sclerosis
  205. Quality of Life and Depression in Police Officers: Perspectives from Chinese in Taiwan
  206. Health-Related Quality of Life in Obsessive-Compulsive Disorder Subjects and their Relatives [1]: Overview
  207. Health-Related Quality of Life in Obsessive-Compulsive Disorder Subjects and Their Relatives [2]: A Systematic Review and Original Data of Assessment of Quality of Life Measured by WHOQOL-BREF
  208. Quality of Life in Bipolar Disorder
  209. Issues in Quality of Life Assessment in Schizophrenia
  210. Health-Related Quality of Life in Parents of Children with Asperger Syndrome and High-Functioning Autism
  211. Quality of Life and Neuropsychological Symptoms in Primary Hyperparathyroidism
  212. Children with Cerebral Palsy, Psychometric Analysis and Quality of Life
  213. Quality of Life in Dementia Patients and Their Proxies: A Narrative Review of the Concept and Measurement Scales
  214. Quality of Life and Drug Abuse
  215. Quality of Life in HIV Positive Injecting Drug Users
  216. Quality of Life Measurement and Alcoholism: A Nursing Perspective
  217. Quality of Life and Psychiatric Symptomatology in Alcohol Detoxification
  218. Quality of Life in Patients Affected by Multiple Sclerosis: A Systematic Review
  219. Quality of Life in People with Lower-Limb Amputation
  220. Quality of Life in Spinal Cord Injury
  221. Quality of Life in Sporadic Adult-Onset Ataxia
  222. Quality of Life in Systemic Sclerosis
  223. Quality of Life in Toenail Onychomycosis
  224. Quality of Life Measures in the Deaf
  225. Hearing Aids and Quality of Life
  226. Cochlear Implantation and Quality of Life in Deafness
  227. Quality of Life Measures for the Visually Impaired: Sub-Sahara Africa
  228. Health-Related Quality of Life in Pain Medicine: A Review of Theory and Practice
  229. Relationship Between Pain and Quality of Life
  230. Quality of Life in Ankylosing Spondylitis and Undifferentiated Spondyloarthropathy: Chinese Perspectives
  231. Quality of Life Measures in Fibromyalgia
  232. Quality of Life and Low Back Pain
  233. Disease Burden, Quality of Life and Other Measures in Polymyalgia Rheumatica
  234. Health-Related Quality of Life in Movement Disorders
  235. Quality of Life Measures in Lower Limb Ischaemia
  236. Quality of Life among Primary Caregivers of Rheumatic Patients - a South American Experience
  237. Quality of Life in Conservatively Treated Lumbar Disc Disease
  238. Quality of Life and Stress in Wheelchair-Users
  239. Exercise and Quality of Life in Menopause
  240. Exercise and Quality of Life in COPD
  241. A10
  242. A10A
  243. A10B
  244. AABR
  245. AAC → Alternative-Augmentative Communication
  246. Abdominal Obesity
  247. ABI → Ankle Brachial Index
  248. Absolute Risk
  249. Abstainer
  250. Accommodation
  251. Accuracy
  252. ACE Inhibitors
  253. Achilles Foot-Screening Project
  254. Acquired Immuno Deficiency Syndrome
  255. ACS → Acute Coronary Syndrome
  256. ACT → Activated Clotting Time
  257. ACTH → Adrenocorticotropic Hormone
  258. Activated Clotting Time
  259. Active Case Finding
  260. Active Epilepsy
  261. Active Surveillance
  262. Activities
  263. Activities of Daily Life
  264. Activity and Participation Restriction
  265. Actual Health Status
  266. Acute CINV
  267. Acute Coronary Syndrome
  268. Acute Gastroenteritis
  269. Acute Heart Attack
  270. Acute Low Back Pain
  271. Acute Phase Reactant
  272. AD → Atopic Dermatitis
  273. ADHD → Attention Deficit Hyperactivity Disorder
  274. ADL → Activities of Daily Life
  275. Adolescence
  276. Adrenal Glands
  277. Adrenocorticotropic Hormone
  278. Adverse Events
  279. Aero Digestive Surgery
  280. AF
  281. Affect
  282. AFFIRM Trial
  283. AGE → Acute Gastroenteritis
  284. Age Weight
  285. Age-Adjusted Rates
  286. Age-Based Mortality Envelope
  287. Age-Standardized
  288. Age-Standardized Rates
  289. Age-Weighting
  290. Age-Weighting Function
  291. Aging Index
  292. Aging Males' Symptoms Scale
  293. Agonist
  294. AIDS → Acquired Immuno Deficiency Syndrome
  295. AIMS → Arthritis Impact Measurement Scales
  296. Alanine Aminotransferase → ALT
  297. Albumin
  298. Alcohol
  299. Alcohol Abuse
  300. Alcohol Dependence
  301. Alcohol Detoxification
  302. Alcohol-Attributable Disease Burden
  303. Alcohol-Related Research
  304. Alcohol-Specific Disease Burden
  305. Alcoholic Beverage
  306. Alcoholism
  307. Alexthymia
  308. Alexthymic → Alexthymia
  309. Alkaline Phosphatase
  310. All-Cause Mortality
  311. ALS → Amyotrophic Lateral Sclerosis
  312. ALS-FRS
  313. ALT
  314. Alternative-Augmentative Communication
  315. Alveolar Echinococcosis
  316. Alveolitis
  317. Ambulatory Care
  318. Amenorrhea
  319. Ametropia
  320. Amor Criteria
  321. AMS → Aging Males' Symptoms Scale
  322. Amyotrophic Lateral Sclerosis
  323. AN → Anorexia Nervosa
  324. Anarthria
  325. Anchor-Based Approach
  326. Androgen
  327. Anemia
  328. Anemia Due to B12 or Folate Deficiency
  329. Anemia of Chronic Disease
  330. Anemia of Chronic Kidney Disease
  331. Anesthesia
  332. Aneurysm
  333. Angina
  334. Angina Pectoris
  335. Angiogram
  336. Ankle Brachial Index
  337. Ankylosing Spondylitis
  338. Annual Growth Rate
  339. Annual Risk of Infection
  340. Annulus Fibrosus
  341. Anorexia Nervosa
  342. Antiarrhythmic Drugs
  343. Anticholinergics
  344. Anticoagulation
  345. Antidepressant Medication
  346. Antigenic Drift
  347. Antigenic Shift
  348. Antihypertensives
  349. Aortic Valve Replacement
  350. Appropriate Treatment
  351. AQOL → Asthma-Related Quality of Life
  352. Aquifer
  353. ARI → Annual Risk of Infection
  354. Arousal
  355. Arrhythmia
  356. Arsenicosis
  357. ARSN → Asian Rotavirus Surveillance Network
  358. Arthritis
  359. Arthritis Impact Measurement Scales
  360. AS
  361. ASD → Autism
  362. Asian Rotavirus Surveillance Network
  363. Asperger Syndrome
  364. ASQOL
  365. Assertive Community Treatment
  366. Assessment
  367. Assessment Scales
  368. Assessment Tool
  369. Assistive Technology
  370. Asthma
  371. Asthma Environmental Interventions
  372. Asthma-Related Quality of Life
  373. AT II Receptor Blockers
  374. ATC
  375. Atherosclerosis
  376. Atherosclerotic Burden
  377. Atopic Dermatitis
  378. Atrial Fibrillation
  379. Attention Deficit Hyperactivity Disorder
  380. Attitudinal Barriers
  381. Attributable Burden
  382. Attributable Risk
  383. Audiogram
  384. Audiologic Evaluations
  385. Audiologic Performance
  386. Audiological Outcome
  387. Audiologist
  388. Auditory Pathways
  389. Australian Jurisdictions
  390. Autism
  391. Average Cost-Effectiveness Ratio
  392. Average Weighted Impact Score
  393. Average Wholesale Price
  394. Average Years of Life Lost
  395. Avoidance
  396. Avolition
  397. AWP → Average Wholesale Price
  398. AYLL → Average Years of Life Lost
  399. B2 Agonist
  400. Back Education
  401. Back Pain
  402. BAHAs → Bone-Anchored Hearing Aids
  403. Balneotherapy
  404. Bariatric Surgery
  405. Barthel Index
  406. BAS-G
  407. BASDAI
  408. BASFI
  409. BASMI
  410. Battery
  411. BCG Vaccine
  412. BD → Bipolar Disorder
  413. BDI → Beck Depression Inventory
  414. Bearing the Burden of Maternal Morbidity
  415. Bearing the Burden of Maternal Mortality
  416. Beck Depression Inventory
  417. Behavioral Risk Factor Surveillance System
  418. Benefit-Cost Ratio
  419. Benign Prostatic Hyperplasia
  420. Benzimadazoles
  421. Best Practice
  422. Beta-Endorphins
  423. Beta-Oxidation
  424. Betrayal Trauma
  425. Between-Treatment Minimal Clinically Importance Change
  426. BIA → Bioelectrical Impedance Analysis
  427. Bibliometric Analysis
  428. Biguanides
  429. Bilevel Positive Airway Pressure
  430. Binary-With-Follow-Up
  431. Binge Drinking
  432. Binge Eating
  433. Binge Eating Disorder
  434. Bioelectrical Impedance Analysis
  435. Biofortification
  436. Biologic Agents
  437. Biological Risk Factors
  438. Biologically Based Practices
  439. Biomarker
  440. Biomedical
  441. Biopsychosocial Model
  442. BIPAP → Bilevel Positive Airway Pressure
  443. Bipolar Disorder
  444. Bisphosphonates
  445. Bladder Disturbances
  446. Blood Brain Barrier
  447. BMD → Bone Mineral Density
  448. BMI → Body Mass Index
  449. BN → Bulimia Nervosa
  450. BOD → Burden of Disease
  451. Bodily Pain
  452. Body Composition
  453. Body Functions and Structures
  454. Body Mass Index
  455. Bone Metastases
  456. Bone Metastases Quality of Life Questionnaire
  457. Bone Mineral Density
  458. Bone-Anchored Hearing Aids
  459. Borderline Personality Disorder
  460. Bowel Dysfunction
  461. BPD → Borderline Personality Disorder
  462. Brain Metastasis
  463. Breakthrough Bleeding
  464. Breast Hypertrophy
  465. Breast Reconstruction
  466. Breast Reduction
  467. BRFSS → Behavioral Risk Factor Surveillance System
  468. Brief Intervention
  469. Bulimia Nervosa
  470. Buprenorphine
  471. Burden
  472. Burden of Care
  473. Burden of Disease
  474. Burnout
  475. BWFU → Binary-With-Follow-Up
  476. C-reactive Protein
  477. CA → Conjoint Analysis
  478. CAD → Coronary Artery Disease
  479. CADIS → Childhood Atopic Dermatitis Impact Scale
  480. CAM → Complementary and Alternative Medicine
  481. CAM Modalities
  482. Canadian Cardiovascular Society Classification System for Stable Angina
  483. Cancer
  484. Cancer Incidence
  485. Cancer Mortality
  486. Cancer-Related Anemia
  487. Cancer-Related Anorexia/Cachexia Syndrome
  488. Cannabis
  489. Cardiac Rehabilitation
  490. Cardiovascular Disease
  491. Cardiovascular Limitations and Symptoms Profile
  492. Cardioversion
  493. Caregiver Burden
  494. Caregiver Burden Scale
  495. Caregiver Crisis
  496. Carotid Endarterectomy
  497. Carotid Intima-Media Thickness
  498. Case Control Study
  499. Case Fatality Rate
  500. Case Management
  501. Categories of Health-Related Quality of Life Measures
  502. Catheter Ablation
  503. Cauda Equina Syndrome
  504. CBPR → Community-Based Participatory Research
  505. CBT → Cognitive Behavioral Therapy
  506. CCQ → Clinical COPD Questionnaire
  507. CD4 Count
  508. CDD → Consumed Daily Dose
  509. CDLQI → Children's Dermatology Life Quality Index
  510. CEA → Cost-Effectiveness Analysis
  511. CEA Incremental
  512. CEACs → Cost-Effectiveness Acceptability Curves
  513. CEBS → Children Ever Born and Children Surviving
  514. Center for Epidemiologic Studies-Depression Scale
  515. cEOAEs → National Screening Programs for Hearing Loss (Netherlands)
  516. CER → Cost-Effectiveness Ratio
  517. Cerebral Palsy
  518. Cerebrospinal Fluid
  519. Cerebrovascular Disease
  520. CES-D
  521. CEYLL → Cohort Expected Years of Life Lost
  522. CFA → Confirmatory Factor Analysis
  523. CFR → Case Fatality Rate
  524. CFS → Chronic Fatigue Syndrome
  525. Chemonucleolysis
  526. Chemotherapy
  527. CHF → Congestive Heart Failure
  528. Child Health Questionnaire
  529. Child-Pugh Score
  530. Childhood Atopic Dermatitis Impact Scale
  531. Childhood Cluster Diseases
  532. Children and Adolescents
  533. Children Ever Born and Children Surviving
  534. Children's Dermatology Life Quality Index
  535. Chinese QOL-35
  536. Chinese Quality of Life Measurement Form - 35 Items
  537. CHQ → Child Health Questionnaire
  538. Chronic Disease
  539. Chronic Fatigue Syndrome
  540. Chronic Illness
  541. Chronic Low Back Pain
  542. Chronic Obstructive Lung Disease
  543. Chronic Obstructive Pulmonary Disease
  544. Chronic Pain
  545. Chronic Pruritus
  546. Chronic Renal Insufficiency
  547. Chronic Respiratory Failure
  548. Chronic Venous Disorders
  549. CI
  550. Circadian Rhythm
  551. Circulating Endothelial Cells
  552. Circulating Endothelial Progenitor Cells
  553. CIS
  554. Clan
  555. CLASP → Cardiovascular Limitations and Symptoms Profile
  556. Classical Test Theory
  557. Classification of Systemic Sclerosis
  558. CLI → Critical Limb Ischaemia
  559. Climacteric
  560. Climatotherapy
  561. Clinic-Based Population
  562. Clinical Attack Rate
  563. Clinical COPD Questionnaire
  564. Clinimetric Tools
  565. Clustering
  566. CMA → Cost-Minimization Analysis
  567. Cocaine
  568. Cochin Hand Function Scale
  569. Cochlea
  570. Cochlear Implant
  571. Cochrane Library
  572. Codon
  573. Cognition
  574. Cognitive Behavioral Therapy
  575. Cognitive Interviews
  576. Cohort
  577. Cohort Expected Years of Life Lost
  578. Cohort Study
  579. COI → Cost-of-Illness
  580. COLD → Chronic Obstructive Lung Disease
  581. Commensurable
  582. Common Risk/Health Factor Approach
  583. Communicable Diseases
  584. Community Care Services
  585. Community Oriented Program for the Control of Rheumatic Disease
  586. Community Periodontal Index of Treatment Need
  587. Community-Based Participatory Research
  588. Community-Based Population
  589. Community-Based Stroke Incidence Studies
  590. Commuting Accident
  591. Comorbid
  592. Comorbidity
  593. Compensated Liver Cirrhosis
  594. Complementary and Alternative Medicine
  595. Complete Blood Cell Count with Differential
  596. Complete Response
  597. Completeness
  598. Comprehensive Psychopathological Rating Scale
  599. Compulsions
  600. Computed Tomography
  601. Conceptual Equivalence
  602. Conceptual Framework
  603. Conceptual Model
  604. Concurrent Validity
  605. Condition-Specific Health-Related Quality of Life
  606. Condition-Specific Instruments
  607. Condition-Specific Measures
  608. Condition-Specific Quality of Life Measure
  609. Condition-Specific Scale
  610. Conductive Hearing Loss
  611. Confirmatory Factor Analysis
  612. Confounder
  613. Confounding
  614. Congenital
  615. Congestive Heart Failure
  616. Conjoint Analysis
  617. Conjugate Vaccine
  618. Connectedness
  619. Conservation of Resources Stress Theory
  620. Construct
  621. Construct Validity
  622. Consumed Daily Dose
  623. Content Validity
  624. Contextual Factors
  625. Contingent Valuation
  626. Convenience Sample
  627. Convergent Validity
  628. Convulsive Epilepsy
  629. COPD
  630. Coping
  631. Coping Mechanisms
  632. Coping Strategies
  633. Cornea
  634. Coronary Artery Bypass Graft
  635. Coronary Artery Disease
  636. Coronary Heart Disease
  637. Correlational
  638. Correlations
  639. Corticotropin-Releasing Hormone
  640. Cortisol
  641. Cost
  642. Cost Perspective
  643. Cost Saving
  644. Cost-Accounting Methods
  645. Cost-Benefit Analysis
  646. Cost-Effective
  647. Cost‐Effectiveness
  648. Cost-Effectiveness Acceptability Curves
  649. Cost-Effectiveness Analysis
  650. Cost-Effectiveness Ratio
  651. Cost-Minimization Analysis
  652. Cost-of-Illness
  653. Cost-Saving Intervention
  654. Cost-Utility Analysis
  655. Coverage
  656. CP → Cerebral Palsy
  657. CP-QOL
  658. CPITN → Community Periodontal Index of Treatment Need
  659. CPRS → Comprehensive Psychopathological Rating Scale
  660. Craving
  661. Creatine Phosphokinase
  662. Creatinine
  663. Criterion Validity
  664. Critical Limb Ischaemia
  665. Crohn's Disease
  666. Cronbach's Alpha Coefficient
  667. Cross-Sectional Study
  668. Cross-Sectional Validity
  669. CRP → C-reactive Protein
  670. Crude Cancer Mortality
  671. Crystalline Lens
  672. CTT → Classical Test Theory
  673. CUA → Cost-Utility Analysis
  674. Cue
  675. Cultural Adaptation
  676. Cumulative Rate
  677. Cumulative Risk
  678. Current Practice
  679. CVD
  680. CVI → Chronic Venous Disorders
  681. Cystic Echinococcosis
  682. Daily Living Skills
  683. DALE → Disability-Adjusted Life Expectancy
  684. DALY
  685. DAS → Disease Activity Score
  686. DASH Diet
  687. 30-Days-Mortality
  688. Daytime Sleepiness
  689. DCD → Disease-Controlled Days
  690. DDD
  691. Deafness
  692. Death Certificate
  693. Death Certification
  694. Death Registration
  695. Decompensated Liver Cirrhosis
  696. Deconditioning
  697. Definitive Host
  698. Delayed CINV
  699. Delta
  700. Delusion
  701. Dementia
  702. Dementia with Lewy Bodies
  703. Demographic
  704. Dental Caries
  705. Dental Caries Status
  706. Dental Plaque
  707. Dento-Alveolar Surgery
  708. Dento-Facial Deformities
  709. Department of Defense Clinic
  710. Dependency Ratio
  711. Depression
  712. Dermatitis Family Impact Score
  713. Dermatology Life Quality Index
  714. Dermatology-Specific Quality of Life
  715. Detection Bias
  716. DFI → Dermatitis Family Impact Score
  717. DFLE → Disability-Free Life Expectancy
  718. DHT → Androgen
  719. Diabetes Mellitus
  720. Diabetic Complications
  721. Diabetic Nephropathy
  722. Diabetic Neuropathy
  723. Diabetic Retinopathy
  724. Diagnostic and Statistical Manual
  725. Diagnostic and Statistical Manual of Mental Disorders
  726. Diet
  727. Dietary Habits
  728. Dimension (of Illness)
  729. Dimensionality
  730. Dimensions
  731. Diopter
  732. Direct Costs
  733. Direct Financial Costs
  734. Directly Observed Therapy Strategy
  735. Disability
  736. Disability Weight
  737. Disability-Adjusted Life Expectancy
  738. Disability-Adjusted Life Years Lost
  739. Disability-Free Life Expectancy
  740. Disability-Related Stress
  741. DISABKIDS
  742. Disaster-Related Psychological Screening Test
  743. Disc Herniation
  744. Discount Rate
  745. Discounting
  746. Discriminant Validity
  747. Discriminate
  748. Disease Activity
  749. Disease Activity Score
  750. Disease Burden
  751. Disease Incidence - Prevalence -Mortality Models
  752. Disease Modifying Antirheumatic Drugs
  753. Disease Reservoir in Human African Trypanosomiasis (HAT)
  754. Disease State
  755. Disease-Controlled Days
  756. Disease-Specific Health-Related Quality of Life Instruments
  757. Disease-Specific HRQOL Measures
  758. Disease-Specific Instruments
  759. Disease-Specific Questionnaires
  760. Disease-Specific Tools
  761. DISMOD
  762. Distribution-Based Approach
  763. DLB → Dementia with Lewy Bodies
  764. DLQI → Dermatology Life Quality Index
  765. DMARDs → Disease Modifying Antirheumatic Drugs
  766. DMF(T)-Index
  767. DNDi → Drug for Neglected Diseases Initiative
  768. Domain
  769. Domain of a HRQOL Questionnaire
  770. DOTS → Directly Observed Therapy Strategy
  771. Double ABCX Model
  772. Drink
  773. Drinking Pattern
  774. Drop Out Rate
  775. DRPST → Disaster-Related Psychological Screening Test
  776. Drug
  777. Drug Abuse
  778. Drug Addiction
  779. Drug Dependency
  780. Drug for Neglected Diseases Initiative
  781. Drug-Resistance
  782. DSM → Diagnostic and Statistical Manual
  783. DSM IV-TR
  784. DSQL → Dermatology-Specific Quality of Life
  785. DTPP
  786. Duodenal Switch (Biliopancreatic Diversion)
  787. Duration of CINV
  788. Duration of Diabetes
  789. DXA
  790. Dysarthria
  791. Dyslipidemia
  792. Dysmenorrhea
  793. Dyspareunia
  794. Dysphagia
  795. Dysphoric
  796. Dyspnea
  797. EA
  798. East African Sleeping Sickness
  799. Eating Disorder Not Otherwise Specified
  800. Eating Disorders
  801. ECA → Epidemiological Catchment Area Study
  802. ECOG Index for Performance Status
  803. Ecological Perspective
  804. Economic Cost
  805. Economic Evaluation
  806. Ecstasy
  807. ED
  808. EDNOS → Eating Disorder Not Otherwise Specified
  809. EDS → Excessive Daytime Sleepiness
  810. EDSS → Expanded Disability Status Scale
  811. Educational Attainment
  812. EFA → Exploratory Factor Analysis
  813. Effect Size d
  814. Electrolarynx
  815. Elicitation Format
  816. ELISA
  817. Emerging Disease
  818. Emetogenicity of Chemotherapies
  819. Emmetropia
  820. Emphysema
  821. Empty-Nest Family
  822. Enabling Factors
  823. Encephalitis
  824. End of Life
  825. End-Stage Renal Disease
  826. Endemic
  827. Endothelium
  828. Endovascular Therapy
  829. Energy Medicine
  830. Enteral Nutrition
  831. Enterococcus
  832. Enuresis
  833. Environmental Barriers
  834. Environmental Burden of Disease
  835. Environmental Domain
  836. Environmental Interventions
  837. EORTC → European Organization for Research and Treatment of Cancer
  838. EORTC QLQ-30 Quality of Life Questionnaire
  839. EPI → Expanded Program on Immunization
  840. Epidemic
  841. Epidemiological Catchment Area Study
  842. Epidemiological Transition
  843. Epidemiology
  844. Epilepsy
  845. Episiotomy
  846. Epworth
  847. EQ-5D
  848. EQ-5D-Y
  849. Erectile Dysfunction
  850. Ergometry
  851. Erythrocyte Sedimentation Rate
  852. Esophageal Atresia with or Without Tracheooesophageal Fistula
  853. Esophageal Speech
  854. ESRD
  855. ESS
  856. ESSG Criteria
  857. Established Smokers
  858. Estrogens
  859. EURO
  860. European Organization for Research and Treatment of Cancer
  861. EUROQOL5+
  862. Excess Mortality
  863. Excess Relative Risk
  864. Excessive Daytime Sleepiness
  865. Exercise Tolerance
  866. Existential Quality of Life Scales
  867. Expanded Disability Status Scale
  868. Expanded Program on Immunization
  869. Expert Group Decision-Making Processes
  870. Exploratory Factor Analysis
  871. Extra-Housing Factors
  872. FAB → French-American-British Classification
  873. Face Validity
  874. Facet Arthropathy
  875. FACT-Br Questionnaire
  876. FACT-G
  877. Factor Analysis
  878. Failed Back Surgery Syndrome
  879. Family Accommodation
  880. Family Dermatology Life Quality Index
  881. Family Functioning
  882. FAMS → Functional Assessment Multiple Sclerosis
  883. FAST
  884. Fasting Plasma Glucose
  885. Fatigue
  886. FBSS → Failed Back Surgery Syndrome
  887. FDLQI → Family Dermatology Life Quality Index
  888. Feasibility
  889. Feasible Effectiveness Potential
  890. Feco-Oral Transmission
  891. FES
  892. Fetus
  893. FFS
  894. Fibromyalgia
  895. Fibromyalgia and Chronic Fatigue Syndrome Rating Scale
  896. Fibromyalgia Impact Questionnaire
  897. Financial Costs
  898. FIND → Foundation for Innovative New Diagnostics
  899. FIQ
  900. First-Ever
  901. Flexural
  902. FLIE → Functional Living Index for Emesis
  903. Floor Effects
  904. FM → Fibromyalgia
  905. Focus Group
  906. Follicle Stimulating Hormone
  907. Follicular Cycle Phase
  908. Force of Infection
  909. Foundation for Innovative New Diagnostics
  910. Fourier Series
  911. FRACTAL Registry
  912. Framingham Risk Scoring
  913. French-American-British Classification
  914. Frequency
  915. Frequency-Volume Chart
  916. FSH → Follicle Stimulating Hormone
  917. Full Health
  918. Full Health Status
  919. Functional Activity
  920. Functional Assessment Multiple Sclerosis
  921. Functional Independence
  922. Functional Limitation-Free Life Expectancy
  923. Functional Living Index for Emesis
  924. Functional Restoration Program
  925. Functional Results
  926. Functional Status
  927. Functioning
  928. Functioning Assessment Short Test
  929. GAD → Generalized Anxiety Disorder
  930. GAF → Global Assessment of Functioning
  931. Gastric Band
  932. Gastroenteritis
  933. Gastrointestinal Tract
  934. Gatekeeper Training
  935. GAVI
  936. GBD → Global Burden of Disease
  937. GBI → Glasgow Benefit Inventory
  938. GC → Glucocorticoids
  939. GDI → Gender-Related Development Index
  940. GDP → Gross Domestic Product
  941. GEM → Gender Empowerment Measure
  942. Gender Empowerment Measure
  943. Gender-Related Development Index
  944. General Domain
  945. General Health
  946. Generalized Anxiety Disorder
  947. Generic Health-Related Quality of Life Instruments
  948. Generic Health‐Related Quality of Life Measures
  949. Generic Measures
  950. Generic Questionnaires
  951. Generic Scale
  952. Generic Tools
  953. Genetic Polymorphism
  954. Genetic Reassortment
  955. Genotype
  956. Geomicrobiology
  957. Gestation
  958. GFFATM → Global Fund to Fight AIDS, Tuberculosis and Malaria
  959. GHSI → Glasgow Health Status Inventory
  960. Giant Cell Arteritis
  961. Glasgow Benefit Inventory
  962. Glasgow Health Status Inventory
  963. Global Alliance for Tuberculosis Drug Development (TB Alliance)
  964. Global Alliance for Vaccine and Immunization
  965. Global Assessment of Functioning
  966. Global Burden of Disease
  967. Global Fund to Fight AIDS, Tuberculosis and Malaria
  968. Global Person Generated Index
  969. GLOBOCAN 2002
  970. Glucocorticoids
  971. GMFCS → Gross Motor Function Classification System
  972. GNI → Gross National Income
  973. Gonadotropin-Releasing Hormone
  974. Gonarthrosis
  975. GPGI → Global Person Generated Index
  976. Graft Thrombosis
  977. Gross Domestic Product
  978. Gross Motor Function Classification System
  979. Gross National Income
  980. Groundwater
  981. Group Therapy
  982. Growth Factor
  983. GTC → Convulsive Epilepsy
  984. Gulf War Syndrome
  985. H2N2
  986. HADS → Hospital Anxiety and Depression Scale
  987. Hallucination
  988. Handicap‐Adjusted Life Years
  989. HAQ → Stanford Health Assessment Questionnaire
  990. HAQ-DI → Health Assessment Questionnaire Disability Index
  991. Harmful Drinking
  992. HAT → Human African Trypanosomiasis
  993. Hazard Ratio
  994. Hazardous Drinking
  995. Hb → Hemoglobin
  996. HDI → Human Development Index
  997. Health
  998. Health Assessment Questionnaire
  999. Health Assessment Questionnaire Disability Index
  1000. Health Attribute
  1001. Health Expectancy
  1002. Health Gap Measures
  1003. Health Inequalities
  1004. Health Outcome
  1005. Health Promotion
  1006. Health Services Research
  1007. Health State
  1008. Health Status
  1009. Health Summary Measures
  1010. Health System Perspective
  1011. Health Utilities Index Mark 3
  1012. Health Utility
  1013. Health Utility Index
  1014. Health-Adjusted Life Expectancy
  1015. Health-Related Quality of Life
  1016. Health-Related Quality of Life for Eating Disorders
  1017. Health-Related Quality of Life Measures
  1018. Healthcare Providers
  1019. Healthcare Purchasers
  1020. Healthy Aging
  1021. Healthy Life Years
  1022. Healthy Lifestyle Habits
  1023. Healthy Pre-Teenagers
  1024. Heart Disease
  1025. Hematolymphatic Stage of Human African Trypanosomiasis
  1026. Hematoma
  1027. Hemoglobin
  1028. Hemoglobin Fluctuations
  1029. Hemoglobinopathy
  1030. Hemorrhagic Stroke
  1031. Hemorrhagic Stroke Subtypes
  1032. Hepatic Encephalopathy
  1033. Hepatitis B Virus
  1034. Hepatitis C Virus
  1035. Herd Immunity
  1036. Heroin
  1037. HERQOLEDv2 → Health-Related Quality of Life for Eating Disorders
  1038. HFA → High-Functioning Autism
  1039. HHVI → Human Hookworm Vaccine Initiative
  1040. Hib
  1041. High Potency Topical Corticosteroids
  1042. High Triglyceride Levels
  1043. High-Functioning Autism
  1044. High-Risk Group
  1045. Highly Cost-Effective Intervention
  1046. HIPAA
  1047. Hirsutism
  1048. HIV → Human Immunodeficiency Virus
  1049. HIV Prevalence
  1050. HMV → Home Mechanical Ventilation
  1051. Hoehn and Yahr Scale
  1052. Holistic Health
  1053. Home Mechanical Ventilation
  1054. Homelessness
  1055. Homocysteine
  1056. Homogenization
  1057. Hormone Replacement Therapy
  1058. Hospice
  1059. Hospital Anxiety and Depression Scale
  1060. Hospital-Based
  1061. Hospitalization
  1062. Hot Flushes
  1063. Housing Choice
  1064. Housing Quality
  1065. Housing Support
  1066. HPA → Hypothalamic-Pituitary-Adrenal Axis
  1067. HPTC → High Potency Topical Corticosteroids
  1068. HPV
  1069. HQLI
  1070. HR → Hazard Ratio
  1071. HRQL → Health-Related Quality of Life
  1072. HRQOL → Health-Related Quality of Life
  1073. HRT → Hormone Replacement Therapy
  1074. HU → Health Utility
  1075. HUI → Health Utility Index
  1076. HUI3 → Health Utilities Index Mark 3
  1077. Human African Trypanosomiasis
  1078. Human Capital Approach
  1079. Human Development Index
  1080. Human Hookworm Vaccine Initiative
  1081. Human Immunodeficiency Virus
  1082. Human Poverty Index (HPI-1 and HPI-2)
  1083. Huntington's Disease
  1084. Hydrotherapy
  1085. Hyperarousal
  1086. Hypercholesterolemia
  1087. Hyperglycemia
  1088. Hyperlipidemia
  1089. Hyperopia
  1090. Hypertension
  1091. Hyperventilation Syndrome
  1092. Hypervigilance
  1093. Hypoglycemic Unawareness
  1094. Hypogonadotropic Hypogonadism
  1095. Hypopnea
  1096. Hypothalamic Amenorrhea
  1097. Hypothalamic-Pituitary-Adrenal Axis
  1098. Hypoventilation
  1099. Hypoxemia
  1100. I-ADL → Instrumental Activities of Daily Living
  1101. IBD → Inflammatory Bowel Disease
  1102. IC → Intermittent Claudication
  1103. ICC → Intra-Class Correlation Coefficients
  1104. ICD → International Classification of Disease
  1105. ICD-9
  1106. ICD-10
  1107. ICER → Incremental Cost-Effectiveness Ratio
  1108. ICF
  1109. ICF Categories
  1110. ICF Checklist
  1111. ICF Core Set
  1112. ICF Qualifier
  1113. ICIDIH → International Classification of Impairment, Disabilities and Handicaps
  1114. IDO → Indoleamine-2,3-Dioxygenase
  1115. IDQOL → Infant's Dermatology Quality of Life Index
  1116. IGA → Investigator's Global Assessment
  1117. IGF-I
  1118. IGRA → Interferon-Gamma Release Assay
  1119. IHD → Ischemic Heart Disease
  1120. IIC → Item-Internal Consistency
  1121. Imipramine
  1122. Immittance Battery
  1123. Immunization
  1124. Immunomodulators
  1125. Immunosuppression Medications
  1126. Impact of Chronic Skin Disease on Daily Life
  1127. Impact of Weight on Quality of Life Questionnaire
  1128. Impact of Weight on Quality of Life-Lite Questionnaire
  1129. Impaired Glucose Tolerance
  1130. IMSS → Mexican Institute of Social Security
  1131. In Vitro Fertilization
  1132. Incidence
  1133. Incremental Cost-Effectiveness Ratio
  1134. Independence Domain
  1135. Index
  1136. Index Date
  1137. Indication for Treatment
  1138. Indicators
  1139. Indigenous Australians
  1140. Indirect Costs
  1141. Individual DALY → Individual Disability-Adjusted Life Year
  1142. Individual Disability-Adjusted Life Year
  1143. Individual Measures
  1144. Individual Quality of Life Scales
  1145. Individual Years of Life Lost
  1146. Individualized Measures
  1147. Individualized Quality of Life Measures
  1148. Indoleamine-2,3-Dioxygenase
  1149. Infant's Dermatology Quality of Life Index
  1150. Infection
  1151. Infertility
  1152. Inflammatory Bowel Disease
  1153. Informal Caregiver
  1154. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials
  1155. Injecting Drug Use
  1156. Injuries
  1157. Insecticide-Treated Net
  1158. Insomnia
  1159. Institutional Cost
  1160. Instrumental Activities of Daily Living
  1161. Insulin
  1162. Insulin-Dependent Diabetes
  1163. Intangible Costs
  1164. Integer Counting
  1165. Intense Physical Activities
  1166. Intensity of Nausea
  1167. Intensity of Vomiting
  1168. Interferon-γ
  1169. Interferon-Gamma Release Assay
  1170. Interim Analysis
  1171. Intermediate Host
  1172. Intermittent Claudication
  1173. Internal Consistency
  1174. International Classification of Disease
  1175. International Classification of Functioning, Disability and Health
  1176. International Classification of Impairment, Disabilities and Handicaps
  1177. International Dollars
  1178. International Prognostic Scoring System
  1179. International Trachoma Initiative
  1180. Interpersonal Sensitivity
  1181. Interstitial Lung Disease
  1182. Intervention Costs
  1183. Intervention Study
  1184. Intimate Partner Violence
  1185. Intra-Class Correlation Coefficients
  1186. Intracerebral Hemorrhage
  1187. Intractable Pruritus
  1188. Intradialytic Parenteral Nutrition
  1189. Intrauterine Growth Restriction
  1190. Intravenous Thrombolysis
  1191. Invasive Home Mechanical Ventilation
  1192. Investigator's Global Assessment
  1193. IPSS → International Prognostic Scoring System
  1194. IPV
  1195. Iron Deficiency Anemia
  1196. IRT → Item Response Theory
  1197. Ischemia
  1198. Ischemic Heart Disease
  1199. Ischemic Stroke
  1200. Ischemic Stroke Subtypes
  1201. ISDL → Impact of Chronic Skin Disease on Daily Life
  1202. Isolation
  1203. Item
  1204. Item Reduction
  1205. Item Response Theory
  1206. 12-Item Short-Form Health Survey
  1207. Item-Internal Consistency
  1208. ITNs → Insecticide-Treated Net
  1209. IVF → In Vitro Fertilization
  1210. IYLL → Individual Years of Life Lost
  1211. Kappa
  1212. Kappa (К) Index
  1213. Karnosky Performance Status
  1214. Keratosis
  1215. Key Informant Interviews
  1216. Kidscreen
  1217. KMOHW → Korea Ministry of Health and Welfare
  1218. Known Group Validity
  1219. KNSO → Korea National Statistical Office
  1220. Korea Ministry of Health and Welfare
  1221. Korea National Statistical Office
  1222. KPS → Karnosky Performance Status
  1223. Kriging
  1224. Kyphoscoliosis
  1225. LAAC → Looked After and Accommodated Children
  1226. Laparotomy
  1227. Larval Stage
  1228. Lasegue Test
  1229. LASEK → Photorefractive Keratectomy
  1230. Laser In Situ Keratomileusis
  1231. LASIK → Laser In Situ Keratomileusis
  1232. Late Effects of Treatment
  1233. Late-Onset Hypogonadism
  1234. Latent Variable
  1235. LDD → Lumbar Disc Disease
  1236. LDH → Lumbar Disc Herniation
  1237. LEAD → Lower Extremity Arterial Disease
  1238. LED → Life Expectancy with Disability
  1239. LEEP → Loop Electrosurgical Excision Procedure
  1240. Legal Blindness
  1241. Legend Duration
  1242. Leisure-Time Physical Activity
  1243. Length of Stay
  1244. Leprosy
  1245. Level of Agreement
  1246. Levels of Physical Activity
  1247. LH → Luteinizing Hormone
  1248. Life Domains
  1249. Life Expectancy
  1250. Life Expectancy with Disability
  1251. Life Table
  1252. Life Years Lost to Disability
  1253. Life Years Saved
  1254. Lifetime Costs of Stroke
  1255. Lifetime Prevalence of Epilepsy
  1256. Light Therapy
  1257. Likert Scale
  1258. Limb Amputation
  1259. Linear Predictor
  1260. Logit Scale
  1261. LOH → Late-Onset Hypogonadism
  1262. Long-Term Oxygen Therapy
  1263. Longitudinal Study
  1264. Longitudinal Validity
  1265. Looked After and Accommodated Children
  1266. Loop Electrosurgical Excision Procedure
  1267. LOS → Length of Stay
  1268. Low Back Pain
  1269. Low Income
  1270. Low Income Countries
  1271. Low-Middle Income Countries/High Income Countries
  1272. Lower Extremity Arterial Disease
  1273. Lower Urinary Tract Symptoms
  1274. LP → Linear Predictor
  1275. LT → Light Therapy
  1276. Lumbar Disc Disease
  1277. Lumbar Disc Herniation
  1278. Lung Volume Reduction Surgery
  1279. LupusQOL
  1280. Luteal Cycle Phase
  1281. Luteinizing Hormone
  1282. Lymph Nodes
  1283. MacNew Health Disease Health-Related Quality of Life Questionnaire
  1284. Macrovascular Complications
  1285. Macular Disease
  1286. Magnetic Resonance Imaging
  1287. Malaria
  1288. Male Hypogonadism
  1289. Malnutrition
  1290. Mammalian Target of Rapamycin
  1291. Mammogram
  1292. Mammography
  1293. Manipulative and Body-Based Methods
  1294. Manual Therapy
  1295. Mapping
  1296. Marginal Structural Model
  1297. Markov Model
  1298. Mastectomy
  1299. Maternal Conditions
  1300. Maternal Morbidity
  1301. Maternal Mortality, ACOG/CDC Definition
  1302. Maternal Mortality, WHO Definition
  1303. MCID
  1304. McMaster-Toronto Arthritis Patient Preference Disability Questionnaire
  1305. MCS → Mental Component Summary
  1306. MD → Macular Disease
  1307. MDG7
  1308. MDGs → Millennium Development Goals
  1309. MDS
  1310. Measles, Mumps and Rubella
  1311. Measure of Health Status
  1312. Measurement Model
  1313. Measurement Tools
  1314. Mechanical Ventilation
  1315. Mediate
  1316. Mediating Factors
  1317. Medical Costs
  1318. Medical Model
  1319. Medical Outcomes Study Short Form Health Survey - 36
  1320. Medicare
  1321. Medicines for Malaria Ventures
  1322. Mediterranean
  1323. Mediterranean Lifestyle Program
  1324. Medline
  1325. MELD → Model for End-Stage Liver Disease Score
  1326. Meningo-Encephalitic Stage of Human African Trypanosomiasis
  1327. Menopause
  1328. Menorrhagia
  1329. Mental Component Summary
  1330. Mental Distress
  1331. Mental Health
  1332. Meta-Analysis
  1333. Metabolic Equivalents
  1334. Metabolic Syndrome
  1335. Metastases
  1336. Methadone
  1337. Methadone Maintenance Therapy
  1338. Methods of Quality of Life Assessment in Dementia
  1339. Mexican Institute of Social Security
  1340. Microdiscectomy
  1341. Micronutrient Malnutrition
  1342. Microvascular Complications
  1343. MIDAS → Myocardial Infarction Dimensional Assessment Scale
  1344. Migrant
  1345. Millennium Development Goals
  1346. Millennium Development Goal 7
  1347. Millennium Development Goal 7 Target 11
  1348. Mind-Body Medicine
  1349. Minimal Clinically Importance Change
  1350. Minimal Clinically Important Difference
  1351. Minimal Hepatic Encephalopathy
  1352. Minimally Invasive Surgery
  1353. Minority
  1354. Mitrofanoff Catheterizable Conduit
  1355. Mixed Hearing Loss
  1356. Mixed Urinary Incontinence
  1357. MLTW → Model Life Tables West
  1358. MM → Multiple Myeloma
  1359. MMR → Measles, Mumps and Rubella
  1360. MMSE
  1361. MMV → Medicines for Malaria Ventures
  1362. Model for End-Stage Liver Disease Score
  1363. Model Life Tables West
  1364. Modeling Uncertainty
  1365. Moderate Drinking
  1366. Moderate Physical Activities
  1367. Moderating Factors
  1368. Modified Radical Mastectomy
  1369. Modular System for Quality of Life
  1370. Molar
  1371. Molimina
  1372. Monte Carlo Methods
  1373. Moral Danger
  1374. Morbidity
  1375. Mortality
  1376. Mortality Rate
  1377. MQLS
  1378. MQOL
  1379. MQOL-CSF
  1380. MR: IR Ratio
  1381. MRS-Modified Rankin Scale
  1382. MS → Multiple Sclerosis
  1383. MSA → Multiple System Atrophy
  1384. MSLT
  1385. MTOR → Mammalian Target of Rapamycin
  1386. Mucositis
  1387. Multi-Item Scale
  1388. Multi-Level Analysis
  1389. Multidisciplinary Approach to Rehabilitation
  1390. Multidisciplinary Teams
  1391. Multigravida
  1392. Multimorbidity
  1393. Multiple Myeloma
  1394. Multiple Regression Analyses
  1395. Multiple Sclerosis
  1396. Multiple Sclerosis Quality of Life -54 Questionnaire
  1397. Multiple System Atrophy
  1398. Munich Quality of Life Dimensions List
  1399. Muscle-Sparing Thoracotomy
  1400. Musculoskeletal Disorder
  1401. Musculoskeletal Pain
  1402. Mutually Exclusive Interventions
  1403. MVQOLI
  1404. 6MWD → Six Minute Walk Distance
  1405. Myalgic Encephalomyelitis
  1406. Myelodysplasia
  1407. Myelodysplastic Syndromes
  1408. Myelography
  1409. Myocardial Infarction
  1410. Myocardial Infarction Dimensional Assessment Scale
  1411. Myopia
  1412. Nail Functions
  1413. NailQOL
  1414. Nandrolone Decanoate
  1415. NASS Lumbar Spine Outcome Assessment Instrument
  1416. National Burden of Disease
  1417. National Health and Nutrition Examination Survey
  1418. National Institute for Health and Clinical Excellence
  1419. National Screening Programs for Hearing Loss (Netherlands)
  1420. National Survey of Chronic Diseases (ENEC)
  1421. National Survey of Demographic Dynamic (ENDD)
  1422. Natural Remedy
  1423. Nature of Injury
  1424. NBD → National Burden of Disease
  1425. ND
  1426. Neck Dissection
  1427. Neck Stoma
  1428. Needs Assessment
  1429. Negative Symptom
  1430. Neglected Diseases
  1431. Neoliberalism
  1432. Neonatal
  1433. Neonatal Conditions
  1434. Net Present Value
  1435. New York Heart Association Classification - The Stages of Heart Failure
  1436. NHANES → National Health and Nutrition Examination Survey
  1437. NHS Trust
  1438. NIDs and SNIDs
  1439. NIH
  1440. NIHSS-National Institute of Health Stroke Scale
  1441. NIR Body Fat
  1442. NLD → Nonverbal Learning Disability
  1443. Nocturia
  1444. Non-Governmental Organizations
  1445. Non-communicable Diseases
  1446. Nonconvulsive Seizures
  1447. Noninvasive Home Mechanical Ventilation
  1448. Nonsteroidal Anti-inflammatory Drugs
  1449. Nonverbal Learning Disability
  1450. Norm for Standard Expected Years of Life Lost Per Death
  1451. Norm-Adjusted Total Standard Expected Years of Life Lost
  1452. Norm-Based Scoring
  1453. Normal Tissue Complication Probability
  1454. Nosocomial
  1455. Nottingham Health Profile
  1456. NP → Nucleus Pulposus
  1457. NTCP → Normal Tissue Complication Probability
  1458. Nucleus Pulposus
  1459. Numbing
  1460. Nursing Home
  1461. Nutritional Counseling
  1462. Nutritional Status
  1463. Nutritional Supplement
  1464. Nutritional Therapy
  1465. NYHA
  1466. OAEs → Otoacoustic Emissions
  1467. Obese
  1468. Obesity
  1469. Obesity-Attributable Deaths
  1470. Objective
  1471. Objective Impact
  1472. Objective Supports
  1473. Objective Well-Being
  1474. Obsessions
  1475. Obsessive-Compulsive Disorder
  1476. Obstructive Sleep Apnea
  1477. OC → Oral Contraceptives
  1478. Occupational Accident
  1479. Occupational Injury
  1480. OCD → Obsessive-Compulsive Disorder
  1481. OCP → Onchocerciasis Control Program
  1482. Odds Ratio
  1483. ODSQ
  1484. OECD → Organization for Economic Co-operation and Development
  1485. OHRQOL → Oral Health-Related Quality of Life
  1486. Older People
  1487. Oligomenorrhea
  1488. Onchocerciasis Control Program
  1489. Onychomycosis
  1490. OnyCOE-tTM Questionnaire
  1491. Operational Measure
  1492. Opiates
  1493. OPV → Oral Polio Vaccine
  1494. OR → Odds Ratio
  1495. Oral Contraceptives
  1496. Oral Health
  1497. Oral Health-Related Quality of Life
  1498. Oral Polio Vaccine
  1499. Oral Rehydration Therapy
  1500. Organization for Economic Co-operation and Development
  1501. ORT → Oral Rehydration Therapy
  1502. Osseointegrated
  1503. Osteoarthritis
  1504. Osteoporosis
  1505. Otoacoustic Emissions
  1506. Otoscopic Examination
  1507. Outcomes
  1508. Outlier Payments
  1509. Ovary (ies)
  1510. Overactive Bladder
  1511. Overall Response Rate
  1512. Overall Survival
  1513. Overestimation
  1514. Overweight
  1515. Oxidative Stress
  1516. P-ADL → Participation Activities of Daily Living
  1517. Package for Mortality Measurement
  1518. PAD → Peripheral Arterial Disease
  1519. Pad Test
  1520. PADAM → Partial Androgen Deficiency in the Aging Male
  1521. Pain
  1522. Pain Catastrophizing
  1523. Pain Management Index
  1524. Palliative
  1525. Pancreas Exocrine Secretions
  1526. Pancreas Transplantation
  1527. Pandemic
  1528. Pandemic Strain
  1529. PANSS
  1530. PAP → Positive Airway Pressure
  1531. Paralytic Ileus
  1532. Parasomnia
  1533. Parathyroidectomy Assessment of Symptoms Score
  1534. Parents Index of Quality of Life in Atopic Dermatitis
  1535. Parents' Proxy-Report
  1536. Parkinson's Disease
  1537. Partial Androgen Deficiency in the Aging Male
  1538. Partial Mastectomy
  1539. Partial Response
  1540. Participation
  1541. Participation Activities of Daily Living
  1542. Participation Restriction
  1543. PAS → Parathyroidectomy Assessment of Symptoms Score
  1544. Passive Surveillance
  1545. Pathogenicity
  1546. Patient Generated Index
  1547. Patient Health Questionnaire
  1548. Patient Reported Outcome
  1549. PBMH → Preference-Based Measures of Health
  1550. PCI → Percutaneous Coronary Interventions
  1551. PCR → Polymerase Chain Reaction
  1552. PCS → Physical Component Summary
  1553. PDD
  1554. PDQ-39
  1555. PDQL
  1556. Pediatric Outcomes Data Collection Instrument
  1557. Pediatric Quality of Life Inventory
  1558. Per Caput
  1559. Perceived Stigma
  1560. Percutaneous Coronary Interventions
  1561. Percutaneous Endoscopic Discectomy
  1562. Performance
  1563. Perimenopause
  1564. Perinatal
  1565. Perineum
  1566. Period Expected Years of Life Lost
  1567. Period Prevalence of Epilepsy
  1568. Periodontal Diseases
  1569. Perioperative Management
  1570. Peripheral Arterial Disease
  1571. Peripheral Vascular Disease
  1572. Person Tradeoff
  1573. Person-Perceived
  1574. Person-Years of Life Lost
  1575. Personality Type
  1576. PEYLL → Period Expected Years of Life Lost
  1577. PGI → Patient Generated Index
  1578. Phantom Limb Pain
  1579. Pharmacoepidemiologic Database
  1580. Pharmacotherapy
  1581. Phenolic Compounds (Polyphenols)
  1582. Photorefractive Keratectomy
  1583. PHQ-9 → Patient Health Questionnaire
  1584. Physical Activity
  1585. Physical Activity Contexts
  1586. Physical Activity Parameters
  1587. Physical Activity Program
  1588. Physical Activity Promotion
  1589. Physical Component Summary
  1590. Physical Disability Stress Scale
  1591. Physical Domain
  1592. Physical Function
  1593. Physical Functioning
  1594. Physical Therapy
  1595. PIQOL-AD → Parents Index of Quality of Life in Atopic Dermatitis
  1596. Pituitary
  1597. PM10
  1598. PMDD → Premenstrual Dysphoric Disorder
  1599. PMI → Pain Management Index
  1600. PMR → Proportional Mortality Rate
  1601. PMS → Premenstrual Syndrome
  1602. PODCI → Pediatric Outcomes Data Collection Instrument
  1603. 5-Point Likert Scale
  1604. Poly-Pill
  1605. Polycystic Ovarian Syndrome
  1606. Polymerase Chain Reaction
  1607. Polymorphism
  1608. Polymyalgia Rheumatica
  1609. Polysaccharide Vaccine
  1610. Polysomnography
  1611. Population Attributable Fraction
  1612. Population Attributable Risk
  1613. Population Health
  1614. Population Health Metrics
  1615. Population Health Scientist
  1616. Population Norm
  1617. Population-Based
  1618. Population-Based Surveillance
  1619. Positive Airway Pressure
  1620. Positive Functioning
  1621. Positive Predictive Value
  1622. Positive Psychology
  1623. Positive QOL
  1624. Positive Symptom
  1625. Positivity
  1626. Post-Exposure Prophylaxis
  1627. Postal Pilot Study
  1628. Postmenopause
  1629. Postnatal
  1630. Posttraumatic Growth
  1631. Posttraumatic Stress Disorder
  1632. Potential Years of Life Lost
  1633. PPP → Purchasing Power Parity
  1634. PQ, LQ, IQ, EQ, AQ -5Q Quotient
  1635. PQOL-AD (Parents of Children with Atopic Dermatitis)
  1636. Pre-Exposure (Long-Term) Prophylaxis
  1637. Pre-Lingually
  1638. Pre-Pilot Studies
  1639. Pre-Teenagers with Chronic Illness(es)
  1640. Pre/Peri/Post-Lingual Deafness
  1641. PRECEDE/PROCEED Program Planning Model
  1642. Precision
  1643. Predictive Validity
  1644. Predictors of HRQOL
  1645. Predisposing Factors
  1646. Preference Weight
  1647. Preference-Based Health-Related Quality of Life
  1648. Preference-Based Measures of Health
  1649. Premature Mortality
  1650. Premature Ovarian Failure
  1651. Premenopause
  1652. Premenstrual Dysphoric Disorder
  1653. Premenstrual Syndrome
  1654. Premolar
  1655. Presbyacusis
  1656. Preterm
  1657. Prevalence
  1658. Primary Amenorrhea
  1659. Primary Care
  1660. Primary Caregiver
  1661. Primary Hyperparathyroidism
  1662. Primary Prevention of Stroke
  1663. Primigravida
  1664. Principal Components Analysis
  1665. Principal-Axes Factoring
  1666. PRK → Photorefractive Keratectomy
  1667. PRO → Patient Reported Outcome
  1668. Probabilistic Decision Analytic Model
  1669. Probabilistic Risk Assessment
  1670. Probabilistic Sensitivity Analysis
  1671. Process Evaluation
  1672. Production Function
  1673. Productivity Cost
  1674. Professional Caregivers
  1675. Profile
  1676. Progestin
  1677. Prognosis
  1678. Program
  1679. Program Evaluation
  1680. Program Perspective
  1681. Progression Free Survival
  1682. Progressive Supranuclear Palsy
  1683. Prophylaxis
  1684. Proportional Mortality Rate
  1685. Prospective Cohort Study
  1686. Prospective Costing
  1687. Prostatitis
  1688. Prosthesis
  1689. Prosthetic Heart Valves
  1690. Prosthetics
  1691. Protection Cost
  1692. Protein-Energy Wasting
  1693. Proxy
  1694. Proxy Questionnaire
  1695. Proxy Rating of Health-Related Quality of Life
  1696. Proxy Rating of Quality of Life in Dementia
  1697. Proxy Report
  1698. Pruritus
  1699. PSA → Probabilistic Sensitivity Analysis
  1700. Pseudoaneurysm
  1701. Pseudoglottis
  1702. PSG → Polysomnography
  1703. Psoriasis
  1704. Psych Info
  1705. Psychological Characteristics
  1706. Psychological Domain
  1707. Psychological Functioning
  1708. Psychological Risk Factors
  1709. Psychometric
  1710. Psychometric Properties
  1711. Psychometric Testing
  1712. Psychometric Tools
  1713. Psychometrics
  1714. Psychopathology
  1715. Psychosis
  1716. Psychosocial Functioning
  1717. Psychotropic
  1718. PTO
  1719. PTSD → Posttraumatic Stress Disorder
  1720. Public Health Recommendations for Physical Activity
  1721. Pulmonary Rehabilitation
  1722. Purchasing Power Parity
  1723. Pure Tone
  1724. PYLL → Potential Years of Life Lost
  1725. QALY → Quality-Adjusted Life Years
  1726. QLMI
  1727. QLQ C-30 Survey
  1728. QODD
  1729. QOL → Quality of Life
  1730. QOL/HRQL → Quality of Life and Health-Related Quality of Life
  1731. QUAL-E
  1732. Qualitative
  1733. Qualitative Research
  1734. Qualitative Validation
  1735. Quality Improvement
  1736. Quality of Life
  1737. Quality of Life and Health-Related Quality of Life
  1738. Quality of Life Measurement in Developing Countries
  1739. Quality of Life Measures
  1740. Quality of Life Tools
  1741. Quality of Life Transition
  1742. Quality of Life Weights
  1743. Quality-Adjusted Life Years
  1744. Quantitative Research
  1745. Quarantine
  1746. Quasi-Experiment
  1747. QUEST
  1748. Questionnaire
  1749. RA → Rheumatoid Arthritis
  1750. Radical Mastectomy
  1751. Randomized
  1752. Randomized Clinical Trial
  1753. Randomized Cluster Sampling
  1754. Randomized Controlled Trial
  1755. Rasch Analysis
  1756. Rate Control
  1757. Rates
  1758. Raynaud's Phenomenon
  1759. RCT → Randomized Controlled Trial
  1760. Reactivity
  1761. Recall
  1762. Recall Dental Patients
  1763. Recombinant Human Erythropoietin (rHuEpo and Darbepoetin alfa)
  1764. Recursive
  1765. Recursive Partitioning Analysis
  1766. Refugee
  1767. Refugee Camps
  1768. Regional Characteristics
  1769. Regression Analysis
  1770. Regression Dilution
  1771. Regression-Kriging
  1772. Rehabilitation
  1773. Rehabilitation Program
  1774. Relapse
  1775. Relationship Deprivation
  1776. Relative Commitment
  1777. Relative Risk
  1778. Reliability
  1779. Religious Characteristics
  1780. Remission
  1781. Remote
  1782. Removable Dental Prosthesis
  1783. Repeat Infections
  1784. Repeated Measures
  1785. Representative Sample
  1786. Reproducibility
  1787. Reproducible
  1788. Residual Limb Pain
  1789. Responder Burden
  1790. Response Scale
  1791. Response Shift
  1792. Response Shift in Quality of Life Measurement
  1793. Responsiveness
  1794. Responsiveness to Change
  1795. Resting Ankle-Brachial Index
  1796. Restless Legs Syndrome
  1797. Retina
  1798. Retinopathy
  1799. Retrocochlear and Central Hearing Losses
  1800. Retroperitoneal
  1801. Retrospective Costing
  1802. Revascularization
  1803. Reverse Causation
  1804. Rheumatic Fever
  1805. Rheumatic Heart Disease
  1806. Rheumatoid Arthritis
  1807. Rhinosinusitus
  1808. Rhythm Control
  1809. Rhythmic Functional Order
  1810. Risk Factor
  1811. Risks
  1812. Role Functioning
  1813. Role-Emotional
  1814. Role-Physical
  1815. Rotavirus
  1816. Rotavirus Gastroenteritis
  1817. Roux-en-Y Gastric Bypass
  1818. RPA → Recursive Partitioning Analysis
  1819. RR → Relative Risk
  1820. Run-In Period
  1821. RV → Rotavirus
  1822. RVGE → Rotavirus Gastroenteritis
  1823. RYGBP → Roux-en-Y Gastric Bypass
  1824. SAF → Smoking-Attributable Fraction
  1825. SAOA → Sporadic Adult-Onset Ataxia
  1826. SAQ
  1827. Scale
  1828. Scale Score
  1829. Schedule for Evaluation of Individual Quality of Life
  1830. Schizophrenia
  1831. School-Based Program
  1832. Science Citation Index
  1833. SCOPE Study
  1834. Scotoma
  1835. Scottish Intercollegiate Guidelines Network
  1836. Screening
  1837. Screening Tools
  1838. SD → Standard Deviation
  1839. Seasonal Affective Disorder
  1840. Seattle Angina Questionnaire
  1841. Secondary Amenorrhea
  1842. Secondary Caregiver
  1843. Secondary Outcome Measures
  1844. Secondary Prevention of Stroke
  1845. SEIQOL → Schedule for Evaluation of Individual Quality of Life
  1846. Self-Anchoring Scales
  1847. Self-Management
  1848. Self-Report
  1849. Self-Reporting Questionnaire
  1850. SEM
  1851. Sensitivity
  1852. Sensitivity Analysis
  1853. Sensitivity to Change
  1854. Sensorineural Hearing Impairment
  1855. Sensorineural Hearing Loss
  1856. Sentinel Hospital
  1857. Septicemia
  1858. Sequelae
  1859. Sequestration
  1860. Serotonin Specific Reuptake Inhibitors
  1861. Sertraline
  1862. Service Activity Data
  1863. Service Evaluation
  1864. Service Interventions
  1865. Servicemember
  1866. SES
  1867. Severity Index Measures
  1868. Severity of Illness
  1869. Sex Hormone Binding Globulin
  1870. Sex Work
  1871. Sexual Disturbances
  1872. Sexual Dysfunction
  1873. Sexual Function Problems
  1874. Sexual Orientation
  1875. Sexual Transmission
  1876. Sexuality
  1877. Sexually Transmitted Infections
  1878. SEYLL → Standard Expected Years of Life Lost
  1879. SEYLLd → Standard Expected Years of Life Lost Per Death
  1880. SEYLLnorm → Standard Expected Years of Life Lost
  1881. SEYLLp → Standard Expected Years of Life Lost Per Person Per Year
  1882. SEYLLt → Total Standard Expected Years of Life Lost
  1883. SF-12
  1884. SF-36
  1885. SH → Sentinel Hospital
  1886. SHBG → Sex Hormone Binding Globulin
  1887. SHEP
  1888. Sickness Impact Profile
  1889. Simple (Total) Mastectomy
  1890. Simultaneous Kidney-Pancreas Transplant (SPK)
  1891. Single Rating, Single-Item Scale
  1892. Sinus Rhythm
  1893. SIP → Sickness Impact Profile
  1894. Six Minute Walk Distance
  1895. Skindex-29
  1896. SLE → Systemic Lupus Erythematosus
  1897. Sleep Apnea
  1898. Sleep Disturbances
  1899. Sleeve Gastrectomy
  1900. SLEQOL
  1901. Slum
  1902. Smoking Prevalence
  1903. Smoking Progression
  1904. Smoking Relapse Rate
  1905. Smoking-Attributable Fraction
  1906. SMPH → Summary Measures of Population Health
  1907. SNHL → Sensorineural Hearing Loss
  1908. Snore
  1909. Social Capital
  1910. Social Care Needs
  1911. Social Communication Characteristics
  1912. Social Domain
  1913. Social Environment
  1914. Social Function
  1915. Social Functioning
  1916. Social Indicators
  1917. Social Model
  1918. Social Phobia
  1919. Social Reinforcing Factors
  1920. Social Risk Factors
  1921. Social Sciences Citation Index
  1922. Social Support
  1923. Societal Cost
  1924. Societal Perspective
  1925. Socio-Dental Indicators
  1926. Socioeconomic Status
  1927. Solid Tumors
  1928. Somatisation
  1929. SoP → Social Phobia
  1930. Sources of Less-Severe Maternal Morbidity
  1931. Sources of Maternal Mortality and Severe Morbidity
  1932. SP → Specific Phobia
  1933. Spa Therapy
  1934. Specific Measure
  1935. Specific Phobia
  1936. Spielberger State-Trait Anxiety Inventory
  1937. Spina Bifida
  1938. Spinal Canal
  1939. Spinal Manipulation
  1940. Spinal Stenosis
  1941. Spondylolysis
  1942. Spondylosis
  1943. Sporadic Adult-Onset Ataxia
  1944. SR → Sinus Rhythm
  1945. SRQ → Self-Reporting Questionnaire
  1946. SRS → Stereotactic Radiosurgery
  1947. SSRIs → Serotonin Specific Reuptake Inhibitors
  1948. Stabilization Exercise
  1949. STAI → Spielberger State-Trait Anxiety Inventory
  1950. Standard Deviation
  1951. Standard Expected Years of Life Lost
  1952. Standard Expected Years of Life Lost Per Death
  1953. Standard Expected Years of Life Lost Per Person Per Year
  1954. Standard Gamble
  1955. Standard Measures
  1956. Standard Population
  1957. Standardized Mortality Ratio
  1958. Standardized Rates
  1959. Standardized Values
  1960. Stanford Health Assessment Questionnaire
  1961. Startle Response
  1962. Steatorrhea
  1963. Stenosis
  1964. Stent
  1965. Stereotactic Radiosurgery
  1966. Steroid Therapy
  1967. Steroids
  1968. Stigma
  1969. Stochastic Analyses
  1970. Stress
  1971. Stress Urinary Incontinence
  1972. Stressor
  1973. Stroke
  1974. Stroke Care Units
  1975. Stroke Model
  1976. Stroke Subtypes
  1977. Stroke Unit Care
  1978. Structural Equation Modeling
  1979. Subarachnoid Hemorrhage
  1980. Subclinical Obsessive-Compulsive Syndrome
  1981. Subjective Impact
  1982. Subjective QOL
  1983. Subjective Support
  1984. Subjective Well-Being
  1985. Substance Use Disorder
  1986. SUD → Substance Use Disorder
  1987. Suicidal Process
  1988. Sulfonylureas
  1989. Summary Measure of Health
  1990. Summary Measures of Population Health
  1991. Summary Scores/Trial Index
  1992. Supported Housing
  1993. Supportive Care
  1994. Surveillance
  1995. Survey
  1996. Survival
  1997. Survival Analysis
  1998. Symptom Checklist Revised
  1999. Symptomatic Infection
  2000. Symptomatic Treatment of Brain Metastases
  2001. Symptomatology
  2002. Syndrome
  2003. Synthesized Disability Weight
  2004. SYST-EUR Trial
  2005. Systematic Review
  2006. Systemic Lupus Erythematosus
  2007. Systemic Sclerosis
  2008. T-Test
  2009. Targeted Agents
  2010. TB → Tuberculosis
  2011. TCP → Tumor Control Probability
  2012. TCS → High Potency Topical Corticosteroids
  2013. TDO → Tryptophan Degradation
  2014. Temozolomide
  2015. Tempromandibular Joint Dysfunction
  2016. Ten Characteristics in Elderly Chinese
  2017. Tender Point
  2018. Test-Retest Reliability
  2019. Th1 Type Immune Response
  2020. Therapeutic Education and Functional Readaptation or Educational Program
  2021. Thoracotomy
  2022. Thrombolysis/ t-PA/ Thrombolytics
  2023. Thrombolytic Therapy
  2024. TIA → Transient Ischemic Attack
  2025. TIME
  2026. Time Discount
  2027. Time Discounting
  2028. Time Preference
  2029. Time Series Studies
  2030. Time-Trade-Off
  2031. Time-Trade-Off Quality of Life Methodology
  2032. Timed Up and Go Test
  2033. TIPS → Transjugular Intrahepatic Portosystemic Shunt
  2034. TMD → Tempromandibular Joint Dysfunction
  2035. Tobacco-Use Prevention
  2036. Toilet Mapping
  2037. Tolerance
  2038. TOMHS
  2039. Topical Corticosteroids → High Potency Topical Corticosteroids
  2040. Total Knee Replacement or Total Knee Arthroplasty
  2041. Total Laryngectomy
  2042. Total Prevalent Burden
  2043. Total Standard Expected Years of Life Lost
  2044. Total Years of Life Lost
  2045. Tracheoesophageal Puncture
  2046. Tracheoesophageal Speech
  2047. Traditional Diet
  2048. Traditional Hearing Aids
  2049. Trans-Hiatal Resection
  2050. Transferrin
  2051. Transient Ischemic Attack
  2052. Transjugular Intrahepatic Portosystemic Shunt
  2053. Transtibial Amputation
  2054. Trauma
  2055. Traumatic Stressor
  2056. Treatment Gap
  2057. Trichiasis
  2058. Trigger Point
  2059. Tropical-Cluster Diseases
  2060. Trypanosoma brucei
  2061. Tryptophan
  2062. Tryptophan Degradation
  2063. Tryptophan Deprivation
  2064. Tsetse Fly
  2065. TUAG → Timed Up and Go Test
  2066. Tuberculosis
  2067. Tuberculosis Testing (Purified Protein Derivative, PPD) and/or QuanteFERON Gold
  2068. Tubewell
  2069. Tumor Control Probability
  2070. Tumor Necrosis Factor Inhibitors
  2071. Turner Syndrome
  2072. TYLL → Total Years of Life Lost
  2073. Type 1 Diabetes Mellitus
  2074. Type 2 Diabetes
  2075. Type A Behavior Pattern
  2076. Type B Personality
  2077. Type D Personality
  2078. U → Utility Score
  2079. Ulcerative Colitis
  2080. Ultrasonography
  2081. UMV → Universal Mass Vaccination
  2082. Uncomplicated Tumor Control Probability (P+)
  2083. Underestimation
  2084. Unemployed
  2085. Unexplained Anemia
  2086. UNHCR → United Nations High Commission for Refugees
  2087. Unified Parkinson's Disease Rating Scale
  2088. Unit of Alcohol
  2089. United Nations
  2090. United Nations High Commission for Refugees
  2091. United Nations Human Settlements Program
  2092. United Nations Population Division
  2093. United Nations Population Fund
  2094. United Nations Relief and Works Agency for Palestine Refugees in the Near East
  2095. Universal Mass Vaccination
  2096. Unmet Health Needs
  2097. Unprovoked Seizures
  2098. Unstable Angina
  2099. Untreated Epilepsy
  2100. UPDRS → Unified Parkinson's Disease Rating Scale
  2101. Urban
  2102. Urban Growth
  2103. Urban Transition
  2104. Urbanization
  2105. Urge Urinary Incontinence
  2106. Urgency
  2107. Urinalysis
  2108. Urinary Incontinence
  2109. US Committee for Refugees and Immigrants
  2110. USCRI → US Committee for Refugees and Immigrants
  2111. USpA
  2112. Utility
  2113. Utility Score
  2114. Utility Value
  2115. VA
  2116. Vaccine
  2117. Vaccine Coverage Rate
  2118. Vaccine Wastage Rate
  2119. Valid (or Validated) Questionnaire
  2120. Validity
  2121. Validity of a Measurement Tool (Questionnaire)
  2122. Value-Based Medicine
  2123. VAMC → Veterans Affairs Medical Center
  2124. Variaglobin
  2125. Varimax Rotation
  2126. VAS → Visual Analogue Scale
  2127. Vascular Diseases
  2128. Vascular System
  2129. VBM → Value-Based Medicine
  2130. VCSS
  2131. Vector Control in HAT
  2132. VEINES-QOL
  2133. Ventilator-Assisted Individuals
  2134. Veteran
  2135. Veteran's Administration
  2136. Veterans Affairs Medical Center
  2137. Victim
  2138. Victimization
  2139. Visual Acuity
  2140. Visual Analogue Scale
  2141. Visual Disability
  2142. Visual Function Index or Test Index of Functional Impairment
  2143. Visual Impairment
  2144. Vital Statistics
  2145. Vitality
  2146. Vomiting Episode
  2147. VZV
  2148. Waist Circumference
  2149. Waiting Lists
  2150. Waiting Time Distribution
  2151. Warfarin
  2152. WB → World Bank
  2153. Weighted Scores
  2154. Weighting
  2155. Well-Being
  2156. Well-Being Measures
  2157. Wellness Approach
  2158. West African Sleeping Sickness
  2159. Western Ontario and McMaster Universities Osteoarthritis Index
  2160. Wheelchair Transfer
  2161. WHO → World Health Organization
  2162. WHO Disability Assessment Schedule II
  2163. WHO Geographically Defined, Mortality Stratified Regions (WHO, 2000)
  2164. WHODAS II
  2165. Whole Brain Radiotherapy
  2166. Whole Medical Systems
  2167. WHOQOL-BREF
  2168. Willingness to Pay
  2169. Withdrawal Symptoms
  2170. Within-Treatment Minimal Clinically Importance Change
  2171. WL → Waiting Lists
  2172. World Bank
  2173. World Health Organization
  2174. World Health Organization Disability Assessment Schedule II
  2175. World Health Organization Quality of Life BREF
  2176. World Health Organization Quality of Life Questionnaire
  2177. World Health Organization Regions
  2178. WTP → Willingness to Pay
  2179. Xerostomia
  2180. Years Lived with Disability
  2181. Years of Healthy Life
  2182. Years of Life Gained
  2183. Years of Life Lost
  2184. Years of Life Lost Age-Standardized Rate
  2185. Years of Life Lost Crude Rate
  2186. Years of Life Lost Due to Mortality
  2187. YLD
  2188. YLG → Years of Life Gained
  2189. YLL → Years of Life Lost
  2190. Zinc Deficiency